The Food Ingredients Sector Just Split in Two — and Every Major Food Brand Will Feel It

One company is selling. Another is buying. Both are spending billions. And every food manufacturer with a supply chain will need to pay attention.

In the span of two weeks in May 2026, two of the largest deals in food ingredients history landed within days of each other. IFF announced it would sell its Food Ingredients business to CVC Capital Partners for $4.3 billion. And US starch giant Ingredion confirmed it is in talks to buy British rival Tate & Lyle for £2.74 billion ($3.7 billion).

Together, these two transactions are worth over $8 billion. They are moving in opposite directions — and they tell a very different story about where the ingredients industry is heading.

IFF Is Getting Out of Food Ingredients

IFF — International Flavors & Fragrances — built its food ingredients arm through years of acquisitions. At its peak, the business generated nearly $3.1 billion in annual sales and around $430 million of EBITDA. But it came with a problem. Selling texturants, emulsifiers, and functional proteins is not the same as selling proprietary flavours. The margins are different. The growth profile is different.

So IFF is walking away.

The deal values the Food Ingredients business at about $4.3 billion — roughly 10x EBITDA. IFF will keep a 10% minority stake worth around $200 million and will pocket roughly $3.8 billion in net cash after close. That money will go toward debt reduction and share buybacks. The deal is expected to close by mid-2027.

IFF CEO Erik Fyrwald called it "an important strategic milestone in ongoing portfolio optimization." In plain terms: IFF decided food ingredients are not its future. The buyer, CVC Capital Partners, is one of Europe's largest private equity firms. CVC is betting it can run the business better as a standalone company — free from the complexity of a large, sprawling conglomerate.

Ingredion Is Going the Other Way

While IFF exits, Ingredion is building. The US ingredients company — which reported net sales of $7.2 billion in 2025 — has put in a conditional cash offer to buy Tate & Lyle for £2.74 billion ($3.7 billion).

Tate & Lyle, with 165 years of ingredient innovation behind it, was already growing before this deal appeared. Its 2024 acquisition of pectin and specialty gums maker CP Kelco for around £1.4 billion had just added a new layer of capability in mouthfeel and texture. The combined business would generate over $10 billion in annual revenue — making it one of the largest dedicated food ingredients companies in the world.

Under UK takeover rules, Ingredion must either make a firm offer or walk away by 17:00 on June 11, 2026. That deadline is less than two weeks away. Tate & Lyle's shares surged 27% when the talks were confirmed.

Ingredion's logic is clear. The food and beverage industry is moving toward fewer, more capable ingredient suppliers. Manufacturers want one partner who can handle fibre fortification, texture, sugar reduction, and stability — not five separate ones. Scale wins those relationships.

Two Camps Are Forming

These two deals reveal a split running through the entire ingredients sector.

On one side: companies simplifying. They are shedding units that are lower-margin or too far from their core. IFF fits here. The goal is to be leaner, higher-margin, and more focused on proprietary science.

On the other side: companies consolidating. They are buying breadth, capability, and global reach. The logic is that food brands want fewer, bigger partners — and size is the best competitive defence in that world.

Every food manufacturer that buys ingredients needs to understand this dynamic now, not after the deals close.

What Happens Next

If Ingredion completes the Tate & Lyle acquisition, it will be the biggest deal in the company's history. It will also put pressure on rivals like DSM-Firmenich, Kerry Group, and Givaudan to respond — either with their own acquisitions or by building niche positions a combined giant cannot easily replicate.

For food manufacturers, the message is direct: your ingredient partners are consolidating. That brings benefits — broader service, fewer contracts, more stability. But it also reduces competition and narrows buying options. Procurement teams should start reviewing key ingredient supplier dependencies now, before the new landscape locks in.

The June 11 Ingredion deadline is the first real signal. A firm offer confirms the wave is moving fast. A walk-away would shock the market — and send Tate & Lyle's share price sharply into reverse overnight.